Image
DG23-0112-Specialties-Diabetes-Hemoglobin-Banner

Diagnosing Diabetes

Summary Display Image
Image
DG23-0112-Specialties-Diabetes-Hemoglobinopathies-US-Images-01

Missing One Diagnosis Is One Too Many

​With a strong predictive value for diabetes complications, HbA1c testing should be done routinely in all people with diabetes at initial assessment and as part of continuing care.

The American Diabetes Association (ADA) recommends using NGSP-certified assays and an A1C goal for adults of ≤6.5% (48 mmol/mol).1

Explore HbA1c Testing Solutions

 

1. American Diabetes Association Professional Practice Committee (2023). 6. Glycemic Targets: Standards of Medical Care in Diabetes-2023. Diabetes Care 46 (Suppl 1), S97-S110.

Testing for Hemoglobinopathies

Summary Display Image
Image
DG23-0112-Specialties-Diabetes-Hemoglobinopathies-US-Images-06

Tackling a Global Health Burden

Hemoglobinopathies are the most common severe single-gene disorders worldwide, with over 330,000 affected infants born annually. Although thalassemia and sickle cell disease are among the most common monogenic hemoglobin disorders in the world, disease awareness is still far from acceptable. To learn more, view "Thalassemia and Sickle Cell: Past, Present and Future" webinar, presented by Dr. Michael Angastinioti and Dr. Daniel E. Bauer.

 

View webinar